Reference
Binquet C, et al. The cost-effectiveness of neonatal versus prenatal screening for congenital toxoplasmosis. PLOS One : 18 Sep 2019. Available from: URL: https://doi.org/10.1371/journal.pone.0221709
Rights and permissions
About this article
Cite this article
Prenatal screening for congenital toxoplasmosis worth extra cost. PharmacoEcon Outcomes News 838, 25 (2019). https://doi.org/10.1007/s40274-019-6270-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-6270-2